Persistent lung abnormalities versus established fibrosis: a prospective study of COVID-19 follow-up
B. Vijayakumar (London, United Kingdom), J. Tonkin (London, United Kingdom), A. Devaraj (London, United Kingdom), K. Philip (London, United Kingdom), C. Orton (London, United Kingdom), S. Desai (London, United Kingdom), P. Shah (London, United Kingdom)
Source: Virtual Congress 2021 – Long COVID - 19
Session: Long COVID - 19
Session type: E-poster
Number: 1155
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Vijayakumar (London, United Kingdom), J. Tonkin (London, United Kingdom), A. Devaraj (London, United Kingdom), K. Philip (London, United Kingdom), C. Orton (London, United Kingdom), S. Desai (London, United Kingdom), P. Shah (London, United Kingdom). Persistent lung abnormalities versus established fibrosis: a prospective study of COVID-19 follow-up. 1155
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
1-year prospective study in severe COPD patients: marker of inflammation, lung function and radiologic evaluation Source: Annual Congress 2007 - Pathophysiology and assessment of COPD Year: 2007
Quantitative analysis of lung sounds for monitoring idiopathic pulmonary fibrosis: a prospective pilot study Source: Eur Respir J, 53 (3) 1802093; 10.1183/13993003.02093-2018 Year: 2019
The added value of comorbidities in predicting survival in idiopathic pulmonary fibrosis: a multicentre observational study Source: Eur Respir J, 53 (3) 1801587; 10.1183/13993003.01587-2018 Year: 2019
Early symptoms in suspected lung cancer: a prospective cohort study Source: Eur Respir J 2001; 18: Suppl. 33, 64s Year: 2001
A multicentre, observational cohort study to determine the efficacy and safety of lumacaftor/ivacaftor in patients with severe lung disease and cystic fibrosis Source: International Congress 2019 – Advances in care and monitoring of cystic fibrosis Year: 2019
Early markers of cystic fibrosis structural lung disease: follow-up of the ACFBAL cohort Source: Eur Respir J, 55 (4) 1901694; 10.1183/13993003.01694-2019 Year: 2020
Nutritional assessment in idiopathic pulmonary fibrosis: a prospective multicentre study Source: ERJ Open Res, 8 (1) 00443-2021; 10.1183/23120541.00443-2021 Year: 2022
Early childhood growth is associated with lung function at 7 years: a prospective population-based study Source: Eur Respir J, 56 (6) 2000157; 10.1183/13993003.00157-2020 Year: 2020
Survival in idiopathic pulmonary fibrosis: results of the IFIGENIA follow up study Source: Eur Respir J 2004; 24: Suppl. 48, 254s Year: 2004
An observational study of the lung clearance index throughout childhood in cystic fibrosis: early years matter Source: Eur Respir J, 56 (4) 2000006; 10.1183/13993003.00006-2020 Year: 2020
Late Breaking Abstract - A composite serum biomarker index for the diagnosis of systemic sclerosis associated interstitial lung disease: a multicentre, observational, cohort study Source: Virtual Congress 2021 – New approaches to diagnostic and prognostic evaluation of interstitial lung diseases of known causes Year: 2021
D-dimer as a predictor of persistent pulmonary function impairment after COVID-19 pneumonia: a prospective observational study Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases Year: 2021
A prospective evaluation of lung ultrasonography in patients with fibrotic interstitial lung diseases; preliminary results. Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018
PROOF: A prospective observational registry to describe the disease course and outcomes of idiopathic pulmonary fibrosis patients in a real-world clinical setting in Belgium and Luxembourg: Exposure in the interim report of 175 IPF patients Source: International Congress 2016 – IPF clinical Year: 2016
Predictors of lung function decline: a retrospective study in COPD patients Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018
Treatment of severe pulmonary hypertension secondary to chronic lung disease: A multicentre study. Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020
Gait speed and prognosis in patients with idiopathic pulmonary fibrosis: a prospective cohort study Source: Eur Respir J, 53 (2) 1801186; 10.1183/13993003.01186-2018 Year: 2019
Lung ultrasound to phenotype chronic lung allograft dysfunction in lung transplant recipients. A prospective observational study. Source: Virtual Congress 2021 – Thoracic ultrasound: future applications and current evidence Year: 2021
Is lung function worsening during adolescence in cystic fibrosis? A retrospective study Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new aspects of risk factors, treatments and diagnosis Year: 2012
Lung ultrasound in children with interstitial lung disease: a pilot study. Source: Virtual Congress 2020 – Tip the hat to paediatric bronchology Year: 2020